Найти книгу: "Just Medicine"

Offers an innovative plan to eliminate inequalities in the American health care and save the lives they endanger Over 84,000 black and brown lives are needlessly lost each year due to health disparities: the unfair, unjust, and avoidable differences between the quality and quantity of health care provided to Americans who are members of racial and ethnic minorities and care provided to whites. Health disparities have remained stubbornly entrenched in the American health care system—and in Just Medicine Dayna Bowen Matthew finds that they principally arise from unconscious racial and ethnic biases held by physicians, institutional providers, and their patients.Implicit bias is the single most important determinant of health and health care disparities. Because we have missed this fact, the money we spend on training providers to become culturally competent, expanding wellness education programs and community health centers, and even expanding access to health insurance will have only a modest effect on reducing health disparities. We will continue to utterly fail in the effort to eradicate health disparities unless we enact strong, evidence-based legal remedies that accurately address implicit and unintentional forms of discrimination, to replace the weak, tepid, and largely irrelevant legal remedies currently available.Our continued failure to fashion an effective response that purges the effects of implicit bias from American health care, Matthew argues, is unjust and morally untenable. In this book, she unites medical, neuroscience, psychology, and sociology research on implicit bias and health disparities with her own expertise in civil rights and constitutional law. In a time when the health of the entire nation is at risk, it is essential to confront the issues keeping the health care system from providing equal treatment to all.

Futurological forecast. What is a post-industrial civilization. Nanotechnologies. Nanomedicine. Immortality. Already now for 3 million dollars it is possible to buy cyber immortality.

A novel about transforming organizations from the author of bestselling business books The Goal and Zapp! The Cure is a novel for managers about transforming an under-performing bureaucratic organization into a boundaryless, fact-driven management culture like the one that made Jack Welch's General Electric so consistently successful. It offers real, practical advice for overcoming political inertia, reinventing the company, and doing it in a year or less. By giving each key character a distinct voice, readers are reminded of people they have met and who may even sit in the desk next to them. These characters interact realistically and act pragmatically, and as a result readers become invested in how these people tackle their challenges and create real solutions. The methods described in the book have been successfully employed at many of high-profile companies, such as Black & Decker, Coleman, Emerson, Parker Hannifin, Textron, United Stationers, and Moen. The Cure argues that modern organizations must be flexible, quick, and boundaryless in order to thrive and survive, but it also shows managers how to make it happen fast. Based on the successful management theories of Dan Paul's General Management Technologies, The Cure accomplishes these things in the form of an entertaining, enlightening, and dramatic business narrative. Jeff Cox (Murrysville, PA) is a creative writer known for weaving progressive business concepts into compelling fiction. He is the coauthor of such business bestsellers as The Goal, Zapp!, and Heroz. Dan Paul (Pittsburgh, PA) is CEO of General Management Technologies, a consulting practice which focuses on the alignment of clients' strategies, work processes, and culture in order to target all the functions of a business on the same priorities. Formerly with General Electric, he's worked with many high-profile clients and spoken at many conferences on strategic management for Business Week and the American Management Association.

A behind-the-scenes look at the most lucrative discipline within biotechnology Bioinformatics represents a new area of opportunity for investors and industry participants. Companies are spending billions on the potentially lucrative products that will come from bioinformatics. This book looks at what companies like Merck, Glaxo SmithKline Beecham, and Celera, and hospitals are doing to maneuver themselves to leadership positions in this area. Filled with in-depth insights and surprising revelations, Digital Code of Life examines the personalities who have brought bioinformatics to life and explores the commercial applications and investment opportunities of the most lucrative discipline within genomics. Glyn Moody (London, UK) has published numerous articles in Wired magazine. He is the author of the critically acclaimed book Rebel Code.